Our network has expanded. PCRN have joined us and rebranded to Momentum Clinical Research.
- Home
- Clinical Trials
High Cholesterol Study Wellington ma
High Cholesterol Study
Do you have high cholesterol or high triglycerides?
Momentum Clinical Research is conducting a clinical study exploring an investigational new drug designed to lower cholesterol and triglyceride levels.
The aim of this study is to better understand the safety of this medication and how the body responds to it.
Description
What to expect
Study details
Ages
18 years or older
Duration
The duration of the study is up to 41 weeks with around 12-14 clinic visits.
Compensation
Eligibility Criteria
You may qualify for this study if you:
- Are aged 18 years or older
- Diagnosed with, or may have, mixed hyperlipidemia
- Have high cholesterol and triglycerides OR non-HDL cholesterol
- Are willing to maintain stable medications and diet
Other criteria will apply.
Description
Mixed hyperlipidaemia means having high cholesterol and high triglycerides, both of which increase the risk of heart disease. Standard treatments in New Zealand include lifestyle changes, statins, fibrates, omega-3 fatty acids, and dietary modification.
Despite current treatments, many people continue to have elevated lipid levels. There is a need for better treatments and medications for people with high cholesterol and high triglycerides.
This studies investigational drug is a new RNA interference (RNAi) administered as subcutaneous injection designed to lower both:
- PCSK9 – a protein that increases LDL cholesterol
- APOC3 – a protein that increases triglycerides
It aims to work by reducing the production of these proteins in the liver, which may help lower cholesterol and triglycerides.
What to expect
If you take part in this study, you will first meet with a study doctor to confirm whether the study is suitable for you.
If eligible you will receive either the investigational drug or a placebo (looks like the investigational medicine but contains no active ingredient) via subcutaneous injection. About 75% of participants will receive the active study drug and 25% will receive the placebo.
You will attend regular clinic visits for health assessments, including physical measurements, blood tests, and general health check-ups. Your safety and wellbeing will be closely monitored by our experienced clinical team throughout the study.
Why join a clinical research study?
- Contribute to the development of treatments
- Learn to manage your condition
- Receive health checks and advice from our professional medical team
Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.